publication venue for
- First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD).. 77. 2009
- Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.. 61. 2006
- Adoptive cellular immunotherapy for the treatment of malignant gliomas.. 39. 2001
- Corrigendum to "Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)" [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978].. 154. 2020
- Immunomodulatory agents changing the landscape of multiple myeloma treatment.. 88 Suppl 1. 2013
- Understanding metastasis in breast cancer to improve detection, monitoring and treatment. 2021
- Promises and challenges of oncology and hematology, including geriatric oncology.. 50. 2004
- Standard Operating Procedures (SOPs) for non-invasive multiple biomarkers detection in an academic setting: A critical review of the literature for the RENOVATE study protocol. 2023
- Ibrutinib-associated dermatologic toxicities: A systematic review and meta-analysis. 2022
- Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes. 2021
- Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis. 2021
- International liquid biopsy standardization alliance white paper. 2020
- Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB). 2020
- Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC). 2019
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. 2018
- Melatonin and breast cancer: Evidences from preclinical and human studies. 2017
- Treatment of metastatic castration-resistant prostate cancer (mCRPC) with enzalutamide. 2016
- Immunotherapy advances in uro-genital malignancies. 2016
- Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review. 2015
- Cardiovascular disease following hematopoietic stem cell transplantation: Pathogenesis, detection, and the cardioprotective role of aerobic training. 2015
- Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy. 2015
- Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology. 2015
- Nab-paclitaxel: a flattering facelift. 2014
- Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents. 2013
- How lenalidomide is changing the treatment of patients with multiple myeloma. 2013
- Immunomodulation as a therapeutic strategy in the treatment of multiple myeloma. 2013
- How to select the optimal therapy for early-stage prostate cancer. 2012
- Therapeutic and prognostic importance of epithelial-mesenchymal transition in liver cancers: insights from experimental models. 2011
- How to select the optimal therapy for early-stage prostate cancer. 2011
- Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection. 2010
- Sequential use of targeted agents in the treatment of renal cell carcinoma. 2010
- Pazopanib: Clinical development of a potent anti-angiogenic drug. 2010
- Optimizing the use of anthracyclines in older patients with breast cancer. 2010
- Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults. 2010
- Adapting treatment for prostate cancer according to risk of disease progression. 2008
- Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. 2008
- Review of gene-expression profiling and its clinical use in breast cancer. 2008
- Is there a role for decision aids in cancer-related decisions? 2007
- Effective chemotherapy for hormone-refractory prostate cancer (HRPC): present status and perspectives with taxane-based treatments. 2006
- Multitargeted therapy: can promiscuity be praised in an era of political correctness? 2006
- Geriatric assessment for oncologists: rationale and future directions. 2006
- Current therapies and advances in the treatment of pancreatic cancer. 2006
- Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice? 2005
- Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinomas. 2005
- Blockade of epidermal growth factor receptor (EGFR) activity. 2005
- Psychiatric issues in older cancer patients. 2003
- Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers. 2003
- Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center. 2003
- Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma. 2003
- Factors influencing treatment patterns of breast cancer patients age 75 and older. 2003
- Critical review on non-myeloablative stem cell transplantation (NST). 2002
- Highlights of contemporary issues in the medical management of prostate cancer. 2002
- Overview of international collaborative group prostate cancer trials. 2002
- High-dose chemotherapy with autologous stem cell rescue for brain tumors. 2002
- Bladder cancer. 2002
- Novel approaches to the treatment of non-small cell lung cancer. 2002
- The multilayered postconfluent cell culture as a model for drug screening. 2000
- A critical review of the management of bladder cancer. 1999
- Fertility and pregnancy after adjuvant chemotherapy for breast cancer. 1998
- Bladder cancer: advances in biology and treatment. 1994
- Autoimmune neutropenia of childhood. 1987
- Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literature. 1986
- Nuclear magnetic resonance: preclinical and clinical studies in tumor detection. 1983